Regulation of cyclin dependent kinase CDK1, cyclin A, cyclin B, topoisomerase I101α, and RAD51 by photodynamic therapy in human epidermoid carcinoma cells A431

被引：0

|

作者：

Ahmad, N ^{[1
]}

Kalka, MSK ^{[1
]}

Mukhtar, H ^{[1
]}

机构：

[1] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1999年 / 112卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

820

引用

收藏

页码：659 / 659

页数：1

相关论文

共 22 条

[21] RETRACTED: Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP (Retracted article. See vol. 39, pg. 739, 2018)
Mantena, Sudheer K.
Sharma, Som D.
Katiyar, Santosh K.
CARCINOGENESIS, 2006, 27 (10) : 2018 - 2027
[22] Impact of ESR1 mutations on endocrine therapy (ET) plus alpelisib benefit in patients with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated, advanced breast cancer (ABC) who progressed on or after prior cyclin-dependent kinase inhibitor (CDK4/6i) therapy in the BYLieve trial
Turner, Nick
Rugo, Hope S.
Ciruelos, Eva M.
Ruiz-Borrego, Manuel
Drullinsky, Pamela
Lerebours, Florence
Prat, Aleix
Bachelot, Thomas
Chia, Stephen
Balbin, Alejandro
Joshi, Mukta
Roux, Estelle
Arce, Christina H.
Akdere, Murat
Juric, Dejan
CANCER RESEARCH, 2022, 82 (04)